Navigating Regulatory Pathways for iPSC-Derived Cell Therapies in Neurology
Time: 12:15 pm
day: Conference Day One
Details:
- Regulatory considerations unique to iPSC-derived allogeneic therapies for CNS indications
- Regulatory considerations of management of investigational device for cell therapy administration
- Opportunities for accelerated pathway
Speakers:
